Health Catalyst (HCAT) Misses Q4 EPS by 40c

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.33), $0.40 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $79.6 million versus the consensus estimate of $80.68 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• cbdMD backs bipartisan hemp regulation bill ahead of November deadline
• Active options: META MSFT MSTR ORCL NFLX NOK IREN HOOD PLTR SMCI GOOG